Document is current
Any future updates will be listed below
-
Authors
Batist, Gerald
Kavan, Petr
Augustin, Lance
Schottel, Janet
Moradian, Jordan
Lee, James T.
Saltzman, Daniel
-
Funding
Funding for this research was provided by:
This investigator initiated phase 2 clinical trial was sponsored by Salspera.
- License Information
-
More Information
Article History
Received: 26 September 2025
Accepted: 12 January 2026
First Online: 27 January 2026
Declarations
:
: Dr. Daniel Saltzman is a Professor of Surgery and Pediatrics and the Chief of Pediatric Surgery at the University of Minnesota. Dr. Saltzman is also the co-founder and chief medical officer of Salspera. Salspera is a biotechnology company centered around bacterial based immunotherapeutics and hold the patents for Salmonella-IL2. This conflict has been extensively disclosed and is managed by the Office of Conflict Administration at the University of Minnesota.
